loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$8.95
Offen:
$9.1
24-Stunden-Volumen:
2,794
Relative Volume:
0.41
Marktkapitalisierung:
$601.02M
Einnahmen:
$277.56M
Nettoeinkommen (Verlust:
$-13.33M
KGV:
-46.63
EPS:
-0.19
Netto-Cashflow:
$-6.54M
1W Leistung:
-3.70%
1M Leistung:
-7.23%
6M Leistung:
+8.35%
1J Leistung:
-20.46%
1-Tages-Spanne:
Value
$8.81
$9.1999
1-Wochen-Bereich:
Value
$8.50
$9.50
52-Wochen-Spanne:
Value
$6.65
$12.20

Pharming Group N V Adr Stock (PHAR) Company Profile

Name
Firmenname
Pharming Group N V Adr
Name
Sektor
Healthcare (1169)
Name
Branche
Biotechnology (678)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
382
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-24
Name
Neueste SEC-Einreichungen
Name
PHAR's Discussions on Twitter

Vergleichen Sie PHAR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PHAR
Pharming Group N V Adr
 8.86 601.02M 277.56M -13.33M -6.54M -0.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
 644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
 120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-09 Eingeleitet Jefferies Buy

Pharming Group N V Adr Aktie (PHAR) Neueste Nachrichten

pulisher
Feb 10, 2025

Pharming Group to participate in February investor conference - GlobeNewswire Inc.

Feb 10, 2025
pulisher
Dec 27, 2024

Pharming Group (OTCMKTS:PHGUF) Shares Cross Above 50 Day Moving Average – Time to Sell? - Defense World

Dec 27, 2024
pulisher
Dec 19, 2024

Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com India

Dec 19, 2024
pulisher
Dec 12, 2024

H.C. Wainwright reiterates Buy on Pharming stock, pediatric trial shows safety and tolerability - Investing.com India

Dec 12, 2024
pulisher
Dec 09, 2024

Jefferies initiates Pharming Group shares with Buy on revenue growth - Investing.com India

Dec 09, 2024
pulisher
Oct 28, 2024

Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com India

Oct 28, 2024
pulisher
Oct 25, 2024

Earnings call: Pharming Group NV reports growth amid CEO transition - Investing.com

Oct 25, 2024
pulisher
Oct 25, 2024

Earnings call: Pharming Group NV sees robust growth in Q3, CEO to step down - Investing.com

Oct 25, 2024
pulisher
Oct 21, 2024

October 2024's Promising Penny Stocks to Watch - Yahoo Finance

Oct 21, 2024
pulisher
Oct 03, 2024

Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance

Oct 03, 2024
pulisher
Aug 05, 2024

Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com

Aug 05, 2024
pulisher
Mar 27, 2023

Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up - Nasdaq

Mar 27, 2023
pulisher
Nov 08, 2022

Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Zacks Investment Research

Nov 08, 2022
pulisher
Jul 25, 2017

PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView

Jul 25, 2017

Finanzdaten der Pharming Group N V Adr-Aktie (PHAR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie PHAR

biotechnology RPRX
$33.42
price up icon 0.27%
biotechnology INSM
$81.06
price down icon 3.05%
biotechnology UTHR
$361.10
price down icon 1.70%
biotechnology SMMT
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
biotechnology BNTX
$120.01
price up icon 1.81%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):